Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)
Clinical trial NCT05882734 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05882734
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-13
- Primary completion
- 2026-09-30
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.